- Home
- PAYP vs RGC Comparison
PAYP vs RGC Comparison
Compare PAYP & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$19.72
HOLD
Current Price
$27.47
Company Overview
Basic Information| Metric | PAYP | RGC |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | Japan | Hong Kong |
| Employees | N/A | N/A |
| Industry | Real Estate | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0B | 11.5B |
| IPO Year | 2026 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PAYP | RGC |
|---|---|---|
| Price | $19.72 | $27.47 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $25.54 | N/A |
| AVG Volume (30 Days) | ★ 867.4K | 88.9K |
| Earning Date | 08-12-2026 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20.92 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.80 | $9.39 |
| 52 Week High | $24.89 | $950.00 |
Technical Indicators
Market Signals| Indicator | PAYP | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 47.79 | 48.46 |
| Support Level | $19.33 | $25.44 |
| Resistance Level | $22.94 | $29.26 |
| Average True Range (ATR) | 1.09 | 2.15 |
| MACD | -0.11 | -0.15 |
| Stochastic Oscillator | 21.34 | 31.62 |
Price Performance
Historical Comparison PAYP
RGC
About PAYP PayPay Corporation American Depository Shares
PayPay is a fintech company jointly owned by Softbank and LY. It was founded in 2018, following the success of Alipay and WeChat Pay in China, and was the pioneering code payment app in Japan. Over the past seven years, it has amassed more than 70 million users and is the market leader in code payments.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.